We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
35 hedge funds and large institutions have $19.6M invested in Atara Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
8% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 12
15.29% less ownership
Funds ownership: 57.88% → 42.58% (-15%)
18% less capital invested
Capital invested by funds: $24.1M → $19.6M (-$4.44M)
27% less funds holding
Funds holding: 48 → 35 (-13)
81% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 16
Holders
35
Holders Change
-13
Holders Change %
-27.08%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
13
Reduced
12
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$533K |
| 2 |
Millennium Management
New York
|
+$509K |
| 3 |
Renaissance Technologies
New York
|
+$186K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$151K |
| 5 |
VPC
Vestal Point Capital
New York
|
+$109K |
